Chronic kidney disease (MRC) is a progressive condition that affects millions of people worldwide. In its late stages, CKD can lead to kidney failure, requiring dialysis or a kidney transplant. Thérapie par cellules souches has emerged as a potential treatment option for late-stage CKD, offering hope for patients with this debilitating condition.
Late-Stage Chronic Kidney Disease: Un aperçu
Late-stage CKD is characterized by a significant decline in kidney function, often leading to a buildup of toxins and fluid in the body. This can cause a range of symptoms, including fatigue, nausea, swelling, and difficulty concentrating. As the disease progresses, patients may experience kidney failure, requiring dialysis or a kidney transplant to survive.
Thérapie par cellules souches: A Potential Treatment Option
Stem cells are unspecialized cells that have the ability to differentiate into various cell types, including kidney cells. Researchers believe that thérapie par cellules souches could potentially regenerate damaged kidney tissue and restore kidney function in patients with late-stage CKD.
